UPDATE -- Barings Corporate Investors Holds April 2017

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
34
UPDATE -- Barings Corporate Investors Holds April 2017 Board Meeting

CHARLOTTE, N.C., April 24, 2017 (GLOBE NEWSWIRE) -- The Board of Trustees of Barings Corporate Investors (the "Trust") met on April 21, 2017. The Trust also conducted its 2017 Annual Meeting of Shareholders.  

The Trust’s Trustees determined that the Trust’s March 31, 2017 net asset value ("NAV") is $292,381,934 or $14.74 per share based on 19,830,088 shares outstanding. The Trust's March 31, 2016 NAV was $282,588,113 or $14.35 per share based on 19,694,642 shares outstanding. The Trust reported a NAV of $281,570,891 or $14.02 per share as of December 31, 2016, based on 19,790,407 shares outstanding. All figures other than December 31, 2016 figures are unaudited.

The Trust’s net investment income for the quarter ended March 31, 2017 was $6,473,792 or $0.33 per share, of which approximately $810,935 or $0.04 per share represented income due to nonrecurring items, compared to $4,808,831 or $0.24 per share for the quarter ended March 31, 2016. For the previous year ended December 31, 2016, net investment income was $22,423,839 or $1.13 per share.

The Trust declared a quarterly dividend of 30 cents per share payable on May 12, 2017 to shareholders of record on May 4, 2017. The Trust had previously paid a 30 cent-per-share dividend for the preceding quarter. The Board of Trustees also approved the continuance of the Trust’s current Investment Services Contract with Barings LLC.

During the quarter ended March 31, 2017 net capital gains of $686,282 or $0.03 per share were realized by the Trust, compared to net capital losses of $1,345,504 or $0.07 per share for the quarter ended March 31, 2016. For the previous quarter ended December 31, 2016, net capital gains of $3,514,203 or $0.18 per share.

At the Annual Meeting, shareholders elected Michael H. Brown, Barbara M. Ginader and Maleyne M. Syracuse as Trustees for three-year terms.

The market price of Barings Corporate Investors as of March 31, 2017 was $15.27, which equates to a 3.60% premium over the March 31, 2017 NAV per share. The Trust’s average quarter-end premium for the 3, 5 and 10-year periods was 10.59%, 14.28% and 12.81%, respectively.

Barings Corporate Investors is a closed-end management investment company advised by Barings LLC. Its shares are traded on the New York Stock Exchange under the trading symbol ("MCI").

Per share amounts are rounded to the nearest cent.

Cautionary Notice: Certain statements contained in this press release may be "forward looking" statements. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made and which reflect management’s current estimates, projections, expectations or beliefs, and which are subject to risks and uncertainties that may cause actual results to differ materially. These statements are subject to change at any time based upon economic, market or other conditions and may not be relied upon as investment advice or an indication of the fund's trading intent. References to specific securities are not recommendations of such securities, and may not be representative of the fund's current or future investments. We undertake no obligation to publicly update forward looking statements, whether as a result of new information, future events, or otherwise.

About Barings LLC Barings is a $280+ billion* global asset management firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. A member of the MassMutual Financial Group, Barings maintains a strong global presence with over 1,700 employees and 600 investment professionals across 41 offices in 17 countries. Learn more at www.barings.com .

*As of March 31, 2017

17/310

 

Brian Whelan, Head of Corporate Communications, 980.417.7700,

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 61

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Tigermed's Strategic Shift: Privatization and Divestment

Updated Category News Views 28

Hang onto your hats, folks, because Tigermed is shaking things up in a big way. The Chinese juggernaut you might know as Hangzhou Tigermed Consulting Co., Ltd. is throwing its hat in the ring for the privatization of Frontage Holdings. But that's not the end of the story—there's a whole restructuring circus coming to town, and they've got big plans to offload some...

Continue Reading
RLX Technology Gears Up for Q3 Earnings Call Ahead

Updated Category News Views 13

Under the Microscope: RLX Q3 2026 Earnings Get ready, because November 20 is shaping up to be a real event for RLX Technology watchers. The e-vapor heavyweight is gonna drop its Q3 results right before the crack of dawn U.S. markets open. Now, that's a time that stirs more coffee pots than debates—at 7:00 AM Eastern Time, to be precise. So, you better be braced for some...

Continue Reading
Electra Defense's $4.7M Contract Fuels USAF Innovation

Updated Category News Views 119

Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...

Continue Reading
Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 103

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
CeQur Revolutionizes Insulin Delivery with Wearable Patch

Updated Category News Views 11

A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...

Continue Reading
Cepheid Expands Diagnostic Potential with IVDR Approval

Updated Category News Views 25

A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...

Continue Reading
SOTERIA and Tempus Unite for Military Cancer Battle

Updated Category News Views 115

The Military Faces Cancer's Grasp: A New Frontline There's a battle brewing in the healthcare world, one distinctly different from the chaos of stock tickers or quarterly earnings. It's about saving lives in a space where tactical precision is everything—cancer care for U.S. military personnel and veterans. SOTERIA Precision Medicine Foundation and Tempus (NASDAQ: TEM)...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 82

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Trimble's New Machine Control Tech Promises Big Gains

Updated Category News Views 50

Trimble's Latest Tech: A Game-Changer? The release of Trimble's MP1087 isn't just another upgrade—it's a leap forward. The folks over at Trimble decided to do some housekeeping with their machine positioning offerings, ditching separate components for a new all-in-one device. This bad boy doesn’t just promise—it delivers up to a 15% bump in uptime, even when...

Continue Reading

Top 5 Most Recently Viewed Articles

PENN Entertainment Partners with Monumental Sports for ESPN BET

Updated Category News Views 163

PENN Entertainment Forms Alliance with Monumental Sports PENN Entertainment, Inc. (NASDAQ:PENN) has reached a significant agreement with Monumental Sports & Entertainment to establish a long-term partnership that focuses on enhancing sports betting experiences in Washington D.C. This collaboration secures PENN access to the online market for its ESPN BET platform, pending...

Continue Reading
Sentral Expands Multifamily Management Ventures in Texas and Bay Area

Updated Category News Views 554

Sentral Expands Its Reach in the Multifamily Sector Sentral, a top-tier Class A multifamily management company, is on a growth path as it announces its latest contracts that strengthen its presence in two major markets. The company is adding three new properties to its extensive portfolio, including a groundbreaking development in Houston and two additional properties in...

Continue Reading
Anticipated IPO Surge in 2025 Promises Exciting Deals Ahead

Updated Category News Views 247

Anticipating a Surge in IPOs for 2025 Investment bankers are gearing up for an exciting year in the equity capital markets. As we look ahead, there's a sense of optimism about new initial public offerings (IPOs) that could shape the financial landscape. This anticipation is fueled by a promising pipeline of well-known companies poised to enter the stock market. Key...

Continue Reading
Erika Kirk Introduces Book and Shares Her Journey on FOX News

Updated Category News Views 249

Erika Kirk's Book Tour Launch on FOX News During an exciting week of interviews on FOX News Media, Erika Kirk will unveil her new book tour for her late husband Charlie Kirk's work titled "STOP, in the Name of God: Why Honoring the Sabbath Will Transform Your Life." This series of interviews will commence on the week of December 8th, featuring discussions that delve into...

Continue Reading
Nutrien and Mosaic Stocks Surge Following Potash Production Cuts

Updated Category News Views 243

Nutrien and Mosaic Experience Stock Price Increases Shares of Nutrien Ltd (NYSE: NTR) have climbed impressively by 3.6%, while Mosaic Co (NYSE: MOS) enjoyed a robust increase of 4.8%. This positive momentum coincides with significant news of a production cut from Belarusian potash supplier Belaruskali. The company's decision to reduce potash production is a strategic move...

Continue Reading